Welcome to LookChem.com Sign In|Join Free
  • or
Benzonitrile, 3-chloro-4-(1-piperazinyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

182181-32-4

Post Buying Request

182181-32-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

182181-32-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 182181-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,2,1,8 and 1 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 182181-32:
(8*1)+(7*8)+(6*2)+(5*1)+(4*8)+(3*1)+(2*3)+(1*2)=124
124 % 10 = 4
So 182181-32-4 is a valid CAS Registry Number.

182181-32-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-chloro-4-(piperazin-1-yl)benzonitrile

1.2 Other means of identification

Product number -
Other names 3-chloro-4-piperazin-1-yl-benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:182181-32-4 SDS

182181-32-4Relevant academic research and scientific papers

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

-

Page/Page column 56, (2008/06/13)

The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions that are mediated by excessive glucocorticoid action.

IMIDAZO[1,2-A]PYRIDINES FOR THE TREATMENT OF CNS AND CARDIAC DISEASES

-

, (2008/06/13)

The present invention relates to imidazo[1,2-a]pyridine compounds of formula (1) STR1 which are dopamine D-4 antagonists and useful as anti-psychotic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 182181-32-4